Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials
Abstract Treatment of ventilated patients with gram-negative pneumonia (GNP) is often unsuccessful. We aimed to assess the efficacy and safety of nebulized amikacin (NA) as adjunctive therapy to systemic antibiotics in this patient population. PubMed, Embase, China national knowledge infrastructure,...
Enregistré dans:
Auteurs principaux: | Jun-Ping Qin, Hui-Bin Huang, Hua Zhou, Yuan Zhu, Yuan Xu, Bin Du |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a62b370790684b078b22fea15bd00d9a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Characteristics of Carbapenem-Resistant Gram-Negative Bacilli in Patients with Ventilator-Associated Pneumonia
par: Amira Mohamed, et autres
Publié: (2021) -
Inhaled amikacin versus placebo to prevent ventilator-associated pneumonia: the AMIKINHAL double-blind multicentre randomised controlled trial protocol
par: Sigismond Lasocki, et autres
Publié: (2021) -
Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
par: Feiyang Zhang, et autres
Publié: (2021) -
Emergence of blaNDM-1 and blaVIM producing Gram-negative bacilli in ventilator-associated pneumonia at AMR Surveillance Regional Reference Laboratory in India.
par: Mithlesh Kumari, et autres
Publié: (2021) -
Multifunctional nanoagents for ultrasensitive imaging and photoactive killing of Gram-negative and Gram-positive bacteria
par: Jiali Tang, et autres
Publié: (2019)